biocryst pharmaceuticals inc
(BCRX:Consolidated Issue Listed on NASDAQ Global Select )
Albert F. LoBuglio M.D.
Former Member of Scientific Advisory Board, BioCryst Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 10 board members in 2 different organizations across 3 different industries.|
See Board Relationships
Dr. Albert F. LoBuglio, M.D., has been Director of the Comprehensive Cancer Center at the University of Alabama, Birmingham since 1983. Dr. LoBuglio has held leadership positions in cancer care and research at Ohio State University and the University of Michigan. His expertise has been sought on numerous National Institutes of Health Study Sections, two terms as a member of the Board of Scientific Councilors at the National Cancer Institute and as a scientific advisory ...
4505 Emperor BoulevardPhone: 919-859-1302
Durham, North Carolina 27703
Board Members Memberships*There is no Board Members Memberships data available.
Georgetown University School Of Medicine
University of Pittsburgh
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Gustav A. Christensen||Chief Executive Officer, President and Director|
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Sijmen de Vries M.D., MBA||Chief Executive Officer and Member of Management Board|
Pharming Group NV
|Flemming Ornskov M.D., MBA, MPH||Chief Executive Officer, Managing Director and Director|
|Joji Nakayama||Chief Executive Officer, President and Representative Director|
Daiichi Sankyo Company, Limited
|¥131.0M||Compensation as of Fiscal Year 2013.|